Kelkar Medicos Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 35 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 51.16%
- Profit Growth 429.80%
- Ebitda 266.21%
- Net Worth 84.27%
- Total Assets 47.63%
About Kelkar Medicos
Kelkar Medicos Private Limited (KMPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 October 1989 and has a history of 35 years and three months. Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Kelkar, Mrunalini Kelkar, Sagar Kelkar, and One other member serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100MH1989PTC053971
- Company No.
053971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kelkar Medicos?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Kelkar  | Director | 01-Jan-2011 | Current |
| Bharat Kelkar | Director | 20-Oct-1989 | Current |
| Mrunalini Kelkar | Director | 20-Oct-1989 | Current |
| Purva Kelkar | Director | 26-Jun-2023 | Current |
Financial Performance of Kelkar Medicos.
Kelkar Medicos Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 51.16% increase. The company also saw a substantial improvement in profitability, with a 429.8% increase in profit. The company's net worth Soared by an impressive increase of 84.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kelkar Medicos?
In 2022, Kelkar Medicos had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hospital Owners Association NashikSagar Kelkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kelkar Medicos?
Kelkar Medicos has a workforce of 21 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kelkar Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kelkar Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.